General Information of the Compound
| Compound ID |
CP0405497
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3R,4R)-4-[(4-hydroxybenzene)amido]pyrrolidin-3-yl 4-({2-[(cyclohexylmethoxy)carbonyl]-6-hydroxyphenyl}carbonyl)-3,5-dihydroxybenzoate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C33H34N2O10
|
||||||||||||||||||
| Molecular Weight |
618.639
|
||||||||||||||||||
| Canonical SMILES |
Oc1ccc(cc1)C(=O)N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)OCC2CCCCC2)c(O)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C33H34N2O10/c36-21-11-9-19(10-12-21)31(41)35-23-15-34-16-27(23)45-32(42)20-13-25(38)29(26(39)14-20)30(40)28-22(7-4-8-24(28)37)33(43)44-17-18-5-2-1-3-6-18/h4,7-14,18,23,27,34,36-39H,1-3,5-6,15-17H2,(H,35,41)/t23-,27-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
RYJIUYPHHDCWNM-YIXXDRMTSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00858, Protein kinase C alpha type
Protein ID: PT01495, Protein kinase C beta type
Protein ID: PT01364, Protein kinase C delta type
Protein ID: PT01271, Protein kinase C epsilon type
Protein ID: PT00938, Protein kinase C eta type